FdaApplication
NDA 215700
Identifiers
- fda_app_no: NDA215700
Properties
| Property | Value |
|---|---|
| applicant_name | INFORLIFE SA |
| application_type | NDA |
| approval_date | 2022-09-15 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | EQ 32MG BASE/250ML (EQ 128MCG BASE/ML) | SOLUTION;INTRAVENOUS |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) | SOLUTION;INTRAVENOUS |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION;INTRAVENOUS |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION;INTRAVENOUS |
4 products